{"id":17073,"date":"2019-05-20T10:55:16","date_gmt":"2019-05-20T09:55:16","guid":{"rendered":"https:\/\/lueders-partner.com\/?p=17073"},"modified":"2022-08-22T11:33:32","modified_gmt":"2022-08-22T10:33:32","slug":"appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag","status":"publish","type":"post","link":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/","title":{"rendered":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&#038;D Company Ncardia AG"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-16989 size-full\" src=\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\" alt=\"\" width=\"760\" height=\"428\" srcset=\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png 760w, https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia-300x169.png 300w\" sizes=\"auto, (max-width: 760px) 100vw, 760px\" \/><\/p>\n<p>Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne. Ncardia emerged from Pluriomics, a biotech company founded in 2001, and is a global reserach and development company in the field of applied stem cell technology with operations in Belgium, the Netherlands and the US. The Company&#8217;s goal is to assist science in the discovery and development of HiPSC medicines, including studies on cardiovascular and neuronal safety and efficacy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>18. April 2019<\/p>\n","protected":false},"author":3,"featured_media":16990,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[1258,24844,1231],"tags":[3009,7049,3025,3399,3812,7052,7060,3881,5041,6973,7057,7061,7046,7048,7055,7058,3020,7053,7034,3813,7051,7047,6404,7056,7050,7059,7054,7045],"class_list":["post-17073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuelles-en","category-health","category-newsitems","tag-anlagevermoegen-en","tag-applied-stem-cell-technology","tag-appraisal","tag-appraisal-contract","tag-assets","tag-belgium","tag-cardiovascular","tag-cologne","tag-company","tag-development","tag-discovery","tag-efficacy","tag-evaluation","tag-field","tag-goal","tag-hipsc-medicines","tag-mobile-assets","tag-netherlands","tag-neuronal-2-en","tag-north-rhine-westphalia","tag-operations","tag-reserach","tag-safety","tag-science","tag-stem-cell","tag-studies","tag-us","tag-ziel-2-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.3 (Yoast SEO v24.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&amp;D Company Ncardia AG - Lueders &amp; Partner GmbH<\/title>\n<meta name=\"description\" content=\"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&amp;D company in applied stem cell technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&amp;D Company Ncardia AG\" \/>\n<meta property=\"og:description\" content=\"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&amp;D company in applied stem cell technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\" \/>\n<meta property=\"og:site_name\" content=\"Lueders &amp; Partner GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-20T09:55:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-22T10:33:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\" \/>\n\t<meta property=\"og:image:width\" content=\"760\" \/>\n\t<meta property=\"og:image:height\" content=\"428\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Lueders &amp; Partner GmbH\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lueders &amp; Partner GmbH\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\"},\"author\":{\"name\":\"Lueders &amp; Partner GmbH\",\"@id\":\"https:\/\/lueders-partner.com\/#\/schema\/person\/5615b3d3d3bbdd6f5880a33414c5e54a\"},\"headline\":\"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&#038;D Company Ncardia AG\",\"datePublished\":\"2019-05-20T09:55:16+00:00\",\"dateModified\":\"2022-08-22T10:33:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\"},\"wordCount\":87,\"publisher\":{\"@id\":\"https:\/\/lueders-partner.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\",\"keywords\":[\"Anlageverm\u00f6gen\",\"applied stem cell technology\",\"Appraisal\",\"appraisal contract\",\"assets\",\"belgium\",\"cardiovascular\",\"Cologne\",\"Company\",\"development\",\"discovery\",\"efficacy\",\"evaluation\",\"field\",\"goal\",\"hipsc medicines\",\"Mobile Assets\",\"netherlands\",\"neuronal\",\"North Rhine-Westphalia\",\"operations\",\"reserach\",\"safety\",\"science\",\"stem cell\",\"studies\",\"us\",\"ziel\"],\"articleSection\":[\"Aktuelles\",\"Health\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\",\"url\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\",\"name\":\"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&D Company Ncardia AG - Lueders &amp; Partner GmbH\",\"isPartOf\":{\"@id\":\"https:\/\/lueders-partner.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\",\"datePublished\":\"2019-05-20T09:55:16+00:00\",\"dateModified\":\"2022-08-22T10:33:32+00:00\",\"description\":\"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&D company in applied stem cell technology.\",\"breadcrumb\":{\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage\",\"url\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\",\"contentUrl\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png\",\"width\":760,\"height\":428},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lueders-partner.com\/en\/950-2-2\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&#038;D Company Ncardia AG\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lueders-partner.com\/#website\",\"url\":\"https:\/\/lueders-partner.com\/\",\"name\":\"Lueders &amp; Partner GmbH\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/lueders-partner.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lueders-partner.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lueders-partner.com\/#organization\",\"name\":\"L\u00fcders & Partner GmbH\",\"url\":\"https:\/\/lueders-partner.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lueders-partner.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2017\/01\/logo.png\",\"contentUrl\":\"https:\/\/lueders-partner.com\/wp-content\/uploads\/2017\/01\/logo.png\",\"width\":135,\"height\":100,\"caption\":\"L\u00fcders & Partner GmbH\"},\"image\":{\"@id\":\"https:\/\/lueders-partner.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lueders-partner.com\/#\/schema\/person\/5615b3d3d3bbdd6f5880a33414c5e54a\",\"name\":\"Lueders &amp; Partner GmbH\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lueders-partner.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b1fce65b43658ab2ac95be23e5f1980b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b1fce65b43658ab2ac95be23e5f1980b?s=96&d=mm&r=g\",\"caption\":\"Lueders &amp; Partner GmbH\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&D Company Ncardia AG - Lueders &amp; Partner GmbH","description":"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&D company in applied stem cell technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/","og_locale":"en_US","og_type":"article","og_title":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&D Company Ncardia AG","og_description":"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&D company in applied stem cell technology.","og_url":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/","og_site_name":"Lueders &amp; Partner GmbH","article_published_time":"2019-05-20T09:55:16+00:00","article_modified_time":"2022-08-22T10:33:32+00:00","og_image":[{"width":760,"height":428,"url":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png","type":"image\/png"}],"author":"Lueders &amp; Partner GmbH","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lueders &amp; Partner GmbH","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#article","isPartOf":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/"},"author":{"name":"Lueders &amp; Partner GmbH","@id":"https:\/\/lueders-partner.com\/#\/schema\/person\/5615b3d3d3bbdd6f5880a33414c5e54a"},"headline":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&#038;D Company Ncardia AG","datePublished":"2019-05-20T09:55:16+00:00","dateModified":"2022-08-22T10:33:32+00:00","mainEntityOfPage":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/"},"wordCount":87,"publisher":{"@id":"https:\/\/lueders-partner.com\/#organization"},"image":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png","keywords":["Anlageverm\u00f6gen","applied stem cell technology","Appraisal","appraisal contract","assets","belgium","cardiovascular","Cologne","Company","development","discovery","efficacy","evaluation","field","goal","hipsc medicines","Mobile Assets","netherlands","neuronal","North Rhine-Westphalia","operations","reserach","safety","science","stem cell","studies","us","ziel"],"articleSection":["Aktuelles","Health","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/","url":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/","name":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&D Company Ncardia AG - Lueders &amp; Partner GmbH","isPartOf":{"@id":"https:\/\/lueders-partner.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage"},"image":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png","datePublished":"2019-05-20T09:55:16+00:00","dateModified":"2022-08-22T10:33:32+00:00","description":"Appraisal contract to evaluate the mobile assets of Ncardia AG from Cologne, a global biotech R&D company in applied stem cell technology.","breadcrumb":{"@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#primaryimage","url":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png","contentUrl":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2019\/05\/ncardia.png","width":760,"height":428},{"@type":"BreadcrumbList","@id":"https:\/\/lueders-partner.com\/en\/newsitems\/appraisal-contract-evaluation-of-the-mobile-assets-of-stem-cell-biotech-rd-company-ncardia-ag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lueders-partner.com\/en\/950-2-2\/"},{"@type":"ListItem","position":2,"name":"Appraisal contract: Evaluation of the Mobile Assets of Stem Cell Biotech R&#038;D Company Ncardia AG"}]},{"@type":"WebSite","@id":"https:\/\/lueders-partner.com\/#website","url":"https:\/\/lueders-partner.com\/","name":"Lueders &amp; Partner GmbH","description":"","publisher":{"@id":"https:\/\/lueders-partner.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lueders-partner.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lueders-partner.com\/#organization","name":"L\u00fcders & Partner GmbH","url":"https:\/\/lueders-partner.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lueders-partner.com\/#\/schema\/logo\/image\/","url":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2017\/01\/logo.png","contentUrl":"https:\/\/lueders-partner.com\/wp-content\/uploads\/2017\/01\/logo.png","width":135,"height":100,"caption":"L\u00fcders & Partner GmbH"},"image":{"@id":"https:\/\/lueders-partner.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lueders-partner.com\/#\/schema\/person\/5615b3d3d3bbdd6f5880a33414c5e54a","name":"Lueders &amp; Partner GmbH","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lueders-partner.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b1fce65b43658ab2ac95be23e5f1980b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1fce65b43658ab2ac95be23e5f1980b?s=96&d=mm&r=g","caption":"Lueders &amp; Partner GmbH"}}]}},"_links":{"self":[{"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/posts\/17073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/comments?post=17073"}],"version-history":[{"count":2,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/posts\/17073\/revisions"}],"predecessor-version":[{"id":51428,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/posts\/17073\/revisions\/51428"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/media\/16990"}],"wp:attachment":[{"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/media?parent=17073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/categories?post=17073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lueders-partner.com\/en\/wp-json\/wp\/v2\/tags?post=17073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}